"It's basically marketing putting on the disguise of education, and that's always a problem," said Arthur Caplan, professor of medical ethics and director of the Center for Bioethics at the University of Pennsylvania in Philadelphia. "Getting an audience (usually of fellow physicians attending industry-sponsored seminars) to change is the goal of the drug company."
According to one recent snapshot, drug company payments totaled at least $7.9 million to Tennessee-based doctors in 2009 and 2010. That was the 11th-highest statewide total found in a recent analysis by ProPublica, a nonprofit news organization that looked at drug companies' disclosures of payments to doctors nationwide.
via tennessean.com
No comments:
Post a Comment